...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: AGM - Jan 7, 2016 - Details
10
Jan 08, 2016 10:43AM
7
Jan 12, 2016 07:15PM
1
Jan 12, 2016 10:50PM
3
Jan 13, 2016 05:08PM
1
Jan 14, 2016 10:03AM
Masila, re: "The trials will start this quarter." Did Don confirm whether that means by the end of January or end of April? Toinv, re: "earliest payouts...would be in three years." ...possibly sooner. Why do you think it will take six? Thanks in advance, PVLee
1
Jan 14, 2016 11:25AM
4
Jan 14, 2016 03:17PM
5
Jan 15, 2016 01:08AM
3
Jan 15, 2016 09:24AM
Share
New Message
Please login to post a reply